This event will focus on the wide-ranging application of this thinking in healthcare, identify the latest trends in achieving patient engagement, and share standout examples and new insights.
Cleveland Clinic CEO Toby Cosgrove said at the PRWeek Conference that the pharmaceutical industry has a responsibility to manage drug costs without the government stepping in
Mayo Clinic's CEO talks about how a trusted name in healthcare has evolved digitally and centered communications on its newsroom while retaining integrity.
Pfizer to acquire cancer drugmaker Medivation; Valeant names new CFO; Apple acquires health data startup
OncoGenex's prostate cancer drug fails in clinical trial; Aetna to exit exchanges in 11 states; pregnant women taking acetaminophen have higher risks for their children
McCann Health, the 2016 Lions Health Network of the Year, and Campaign invited top marketers and visionary artists to discuss creativity during this year's Lions Health festival.
The power of hackathons is now magnified because of the power of the internet and social media, giving both patients and healthcare professionals a global platform for their voices.
The FDA approves generic versions of AstraZeneca's Crestor; Biogen CEO steps down; drugmakers race to develop smart inhalers
Such intense interest in health content is a rich opportunity to engage, inform, support, and motivate key customer constituencies.
It is the group's first acquisition since it was assembled in February under CEO Karen van Bergen.
The Siri for Seniors took the top prize at the second MM&M Shark Tank for its annual healthcare conference.
Industry is partnering with Watson to try and solve some of healthcare's most pressing questions.
Already, there's cognitive cooking for your kitchen and cognitive coaching for your daily run. What's Watson's vision for medicine?
Learn about Merck's new innovation team as well as read profiles of 9 other teams at companies such as Google and Johnson & Johnson.
Given the value of its data and its relatively backward security measures, the healthcare industry has become a prime target for hackers. But industry experts say changes are afoot.
Digital health technology for low-income consumers is growing and can be very effective when applied appropriately, a report finds.
The agency brought on Penny Mitchell to lead its U.S. health practice.
When it came to the issue of patient-centricity, each of us harbored at least a hint of cynicism.
FitzPatrick is departing the company as it evaluates its 150 agency partnerships.
The Silicon Valley gadget guru who helped define the beyond-the-pill era will talk about embedding nontraditional capabilities into biopharma business models.
Nashville-based ReviveHealth posted $8.7 million in revenue in 2014.
Rick Berke, executive editor of Stat, talks about the title's strategy to make health, medicine and life sciences content compelling and deliver this news to a general audience.
Join us to learn about the opportunities and pitfalls of the new wave of hackathons on healthcare, and learnings from the last three MDP Hackathons.
By breaking down traditional organizational silos to bring together the chief medical officer and the chief marketing officer, companies can unite the forces of clinical best practices with direct-to-consumer response marketing.
An MM&M roundup of what the festival's most inspirational speakers had to say about creativity in healthcare and challenges like talent recruitment and implementing digital innovation.
Value is a concept that concerns all healthcare stakeholders.
A deep dive by the think tank Center for Talent Innovation indicates pharma and payers need to widen their definition of health when communicating with women.
Sen. Hillary Clinton unveiled her healthcare plan, promising to cover all Americans if elected president - and taking a few swipes at the pharmaceutical and insurance industries.
- Sunovion hires former BI exec as VP of marketing
- Five things for pharma marketers to know: Tuesday, October 25, 2016
- Five things for pharma marketers to know: Monday, October 24, 2016
- Five things for pharma marketers to know: Wednesday, October 26, 2016
- If Roche's Ocrevus is approved, the already competitive MS market will gain another player
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy